An attempt in Congress to permit the importation of low-cost prescription medications was thwarted on May 7.
An amendment to a Food and Drug Administration (FDA) drug safety bill (S 1082 [http://thomas.loc.gov]) allowing such importation was approved in the Senate, but not until it was modified with language requiring imported medications to be certified for safety by the Secretary of Health and Human Services. Although the amendment allows for the purchase of FDA-approved drugs that are manufactured at FDA-inspected facilities in 19 countries, safety certification is highly unlikely because drug importation is opposed by the White House.
Mitka M. Drug Importation Thwarted. JAMA. 2007;297(22):2465. doi:10.1001/jama.297.22.2465-a
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: